01 February 2018

Klöckner Pentaplast announces major Pharma Capacity Expansion in Switzerland to Support Growing EMEA & Asian Markets

Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division (kp Pharma) announces a 5 million Euro investment in their Bern, Switzerland facility. kp will expand capacity at its Swiss facility by 30% to address ever-changing market needs in EMEA and support expansion into Asia. 
Tracey Peacock, President, Pharmaceutical & Medical Device Films at kp, says, “We are seeing substantial growth in our barrier product segments in EMEA in response to the increased moisture and oxygen sensitivity of new drugs. We are excited to add significant capacity to our Bern facility to support these trends in our market place.” 

This latest investment comes less than 2 years after the addition of significant laminating capacity in EMEA with the expansion of the Pharmaceutical manufacturing center in Montabaur, Germany. The new capacity will also support the Asian market as it continues to experience double-digit growth. Ms. Peacock went on to say, “We have been quietly adding to our capabilities in EMEA, and now we must accelerate addressing the growing Asian market place. Asia provides excellent opportunities for kp as regulation continues to increase with many EMEA and US standards being adopted. We are invigorated by the opportunities, and this expansion, supported by local manufacturing and slitting capability in Thailand and China, is just the beginning of some exciting plans we have.” 

The new capability can be expected to be operational by the end of 2018 with the “simple aim of improving service to our customers wherever they may be in the world,” Peacock concluded. 
To learn more about Klöckner Pentaplast and the pharmaceutical and medical device products, visit at the kp team at Booth A60 at Pharmapack Europe 2018, February 7-8, 2018, in Paris, France. 


About Klöckner Pentaplast 

Focused on delivering its vision: The Sustainable Protection of Everyday Needs, kp is a global leader in rigid and flexible packaging, and specialty film solutions, serving the pharmaceutical, medical device, and protein markets, amongst others. With a broad and innovative portfolio of packaging and product films and services, kp plays an integral role in the customer value chain by safeguarding product integrity, protecting brand reputation and improving sustainability. kp’s “Investing in Better” sustainability strategy solidifies its commitment to achieving ten clear targets for long-term improvement by increasing recycling and recyclability of products, cutting carbon emissions and continuous improvement in employee engagement, safety, and diversity, equity and inclusion. kp has earned a gold rating from EcoVadis, the leading platform for environmental, social, and ethical performance ratings, putting kp in the top 3% of companies rated in the manufacturing of plastics products sector. Founded in 1965 kp has 31 plants in 18 countries and employs over 5,700 people committed to serving customers worldwide in over 60 locations. 

Media Contacts:
Dawn Trail
Group Director, Global Communications

+49 (0)2602 915 703